Myocardial Infarct Size Reduction Provided by Local and Remote Ischaemic Preconditioning: References Values from the Hatter Cardiovascular Institute Xavier RosselloZhenhe HeDerek M. Yellon SHORT COMMUNICATION Open access 14 April 2018 Pages: 127 - 133
Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes Yochai BirnbaumMandeep BajajYumei Ye ORIGINAL ARTICLE 05 March 2018 Pages: 135 - 145
Pterostilbene Decreases Cardiac Oxidative Stress and Inflammation via Activation of AMPK/Nrf2/HO-1 Pathway in Fructose-Fed Diabetic Rats Ramoji KosuruVidya KandulaSanjay Singh ORIGINAL ARTICLE 20 March 2018 Pages: 147 - 163
The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway Helison Do CarmoSapna ArjunSean M Davidson SHORT COMMUNICATION Open access 26 March 2018 Pages: 165 - 168
Effect of Antazoline on Electrophysiological Properties of Atrial Muscle and Conduction System of the Heart Bartłomiej Jacek BińkowskiMarcin MakowskiAndrzej Lubiński ORIGINAL ARTICLE Open access 06 April 2018 Pages: 169 - 173
Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials Harold E. BaysRobert S. RosensonG. Kees Hovingh SHORT COMMUNICATION Open access 07 April 2018 Pages: 175 - 180
Correction to: Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials Harold E. BaysRobert S. RosensonG. Kees Hovingh Correction 27 April 2018 Pages: 181 - 181
An Exploratory Study of Dapagliflozin for the Attenuation of Albuminuria in Patients with Heart Failure and Type 2 Diabetes Mellitus (DAPPER) Fumiki YoshiharaMiki Imazuon behalf of the DAPPER investigators and study coordinators ORIGINAL ARTICLE 28 March 2018 Pages: 183 - 190
Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry Ioanna XanthopoulouVasiliki-Maria Dragonafor the GRAPE-AF Investigators ORIGINAL ARTICLE 20 April 2018 Pages: 191 - 196
Association of Abnormal Serum Potassium Levels with Arrhythmias and Cardiovascular Mortality: a Systematic Review and Meta-Analysis of Observational Studies Liesa K. HoppeDana C. MuhlackBen Schöttker REVIEW ARTICLE 20 April 2018 Pages: 197 - 212
Do the SGLT-2 Inhibitors Offer More than Hypoglycemic Activity? Eduardo FloresCarlos G. Santos-GallegoJuan Jose Badimon REVIEW ARTICLE 20 April 2018 Pages: 213 - 222
Old Drugs for New Indications in Cardiovascular Medicine Yaron ArbelWael AbuzeidMichael E. Farkouh REVIEW ARTICLE 10 April 2018 Pages: 223 - 232
Analytic Approaches for the Treatment of Hyperhomocysteinemia and Its Impact on Vascular Disease Soo-Sang KangRobert S. Rosenson REVIEW ARTICLE 20 April 2018 Pages: 233 - 240